ENCALS Satellite meeting 2018, Glasgow

6 December 2018
The ENCALS satellite meeting 2018 was held in Glasgow, UK, on Thursday 6th of December 13.30 – 17.00. This satellite meeting was prior to the 29th International Symposium on ALS/MND on 7-9 December 2018. The goal of this satellite symposium was to discuss international collaborations, SOPs and translation of new developments to the clinic. 

Programme ENCALS satellite meeting 2018

The ENCALS executive board thanks all presenters

  • Julian Gold – Antiretroviral therapy and ALS: The Lighthouse Project
  • Esther Kruitwagen-van Reenen – Home-monitoring in ALS/MND care: patients’ and professionals’ experiences with personalized ALS/MND care through eHealth
    view abstract
  • Bahman Nasseroleslami – Neuroelectric Biomarkers of Network Dysfunction in Amyotrophic Lateral Sclerosis
    view abstract
  • Mamede de Carvalho – OnWebDuals Consortium: Spreading in ALS
    view abstract
  • Christian Lunetta – Edaravone: one year experience of the Italian MND Study Group
    view abstract
  • Tommy Bunte and Japie Bakers – Discussing TRICALS e-modules regarding the outcome measures muscle strength (HHD) and ALS-FRSR
  • Nigel Leigh on behalf of the MIROCALS Consortium – The Challenge of Recruiting Newly Diagnosed Riluzole-Naïve ALS subjects to Clinical Trials: The MIROCALS Experience
    view abstract
  • Nathalie Braun – Slow progressors and Edaravone trials: Is the MCI-186 study a statistical artefact
    view abstract
  • Deirdre Murray – REVEALS: Registry of Endpoints and Validated Experiences in ALS
    view abstract
  • Magdalena Kuzma-Kozakiewicz – The attitude of neurologists to the end-of-life care in amyotrophic lateral sclerosis – comparison between Germany and Poland

Venue

The ENCALS satellite meeting was at the conference venue of the MND symposium: Scottish Event Campus (SEC) Glasgow, Scotland, UK G3 8YW

Meeting room: Alsh 1 and 2